Juvenile myoclonic epilepsy is a common type of epilepsy with onset occurring during adolescence. This review provides a collection of evidence relating to the treatment of this type of epilepsy. Historically, the large majority of patients become seizure-free when treated with valproate. Over recent years, there has been a marked improvement in the pharmacological armamentarium by the physicians. Currently, administration of new antiepileptic drugs, such as levetiracetam, lamotrigine and topiramate, seems to have beneficial effects in the patients with poor response to valproate
The treatment of juvenile myoclonic epilepsy / Verrotti A; Manco R; di Marco G; Chiarelli F; Franzoni E.. - In: EXPERT REVIEW OF NEUROTHERAPEUTICS. - ISSN 1473-7175. - STAMPA. - 6:6(2006), pp. 847-854. [10.1586/14737175.6.6.847]
The treatment of juvenile myoclonic epilepsy
FRANZONI, EMILIO
2006
Abstract
Juvenile myoclonic epilepsy is a common type of epilepsy with onset occurring during adolescence. This review provides a collection of evidence relating to the treatment of this type of epilepsy. Historically, the large majority of patients become seizure-free when treated with valproate. Over recent years, there has been a marked improvement in the pharmacological armamentarium by the physicians. Currently, administration of new antiepileptic drugs, such as levetiracetam, lamotrigine and topiramate, seems to have beneficial effects in the patients with poor response to valproateI documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
